Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

ClinicalTrials.gov ID: NCT00513617

Public ClinicalTrials.gov record NCT00513617. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Arginine Supplementation in Sickle Cell Anemia: Physiological and Prophylactic Effects

Study identification

NCT ID
NCT00513617
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Other
Enrollment
128 participants

Conditions and interventions

Interventions

  • Arginine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
5 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Aug 31, 2007
Completion
Dec 31, 2007
Last update posted
Mar 28, 2017

2004 – 2008

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Children's Hospital of Oakland and Research Institute Oakland California 94609
University of California - San Francisco San Francisco California 94143
University of Colorado at Denver and Health Sciences Center--Sickle Cell Treatment and Research Center Denver Colorado 80262
Kosair Children's Hospital Louisville Kentucky 40202
Boston Medical Center Boston Massachusetts 02118
University of Mississippi Medical Center (Adult) Jackson Mississippi 39215
University of Mississippi Medical Center (Pediatric) Jackson Mississippi 39215
Montefiore Medical Center The Bronx New York 10463
Children's Hospital of Montefiore The Bronx New York 10467
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Duke University Medical Center Durham North Carolina 27710
Children's Hospital of Oklahoma Oklahoma City Oklahoma 73104
Thomas Jefferson University Philadelphia Pennsylvania 19107
St. Christopher's Children's Research Hospital Philadelphia Pennsylvania 19134
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19444
St. Jude Children's Research Hospital Memphis Tennessee 38105
Children's Medical Center of Dallas Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00513617, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00513617 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →